rs2293870

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002775.5(HTRA1):​c.108G>C​(p.Gly36Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.132 in 1,101,636 control chromosomes in the GnomAD database, including 10,663 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G36G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.10 ( 1146 hom., cov: 32)
Exomes 𝑓: 0.14 ( 9517 hom. )

Consequence

HTRA1
NM_002775.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: -1.25

Publications

32 publications found
Variant links:
Genes affected
HTRA1 (HGNC:9476): (HtrA serine peptidase 1) This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7. [provided by RefSeq, Jul 2008]
HTRA1 Gene-Disease associations (from GenCC):
  • CARASIL syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • genetic cerebral small vessel disease
    Inheritance: AD Classification: STRONG Submitted by: Franklin by Genoox
  • HTRA1-related autosomal dominant cerebral small vessel disease
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 10-122461760-G-C is Benign according to our data. Variant chr10-122461760-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 21325.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.25 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.152 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HTRA1NM_002775.5 linkc.108G>C p.Gly36Gly synonymous_variant Exon 1 of 9 ENST00000368984.8 NP_002766.1 Q92743

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HTRA1ENST00000368984.8 linkc.108G>C p.Gly36Gly synonymous_variant Exon 1 of 9 1 NM_002775.5 ENSP00000357980.3 Q92743
HTRA1ENST00000648167.1 linkc.154+3051G>C intron_variant Intron 1 of 8 ENSP00000498033.1 A0A3B3IU24

Frequencies

GnomAD3 genomes
AF:
0.104
AC:
15298
AN:
147106
Hom.:
1146
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0262
Gnomad AMI
AF:
0.123
Gnomad AMR
AF:
0.107
Gnomad ASJ
AF:
0.134
Gnomad EAS
AF:
0.000594
Gnomad SAS
AF:
0.0292
Gnomad FIN
AF:
0.164
Gnomad MID
AF:
0.0545
Gnomad NFE
AF:
0.155
Gnomad OTH
AF:
0.112
GnomAD2 exomes
AF:
0.0595
AC:
1060
AN:
17818
AF XY:
0.0579
show subpopulations
Gnomad AFR exome
AF:
0.0245
Gnomad AMR exome
AF:
0.0343
Gnomad ASJ exome
AF:
0.0706
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0918
Gnomad NFE exome
AF:
0.0895
Gnomad OTH exome
AF:
0.0761
GnomAD4 exome
AF:
0.136
AC:
130142
AN:
954426
Hom.:
9517
Cov.:
32
AF XY:
0.135
AC XY:
61811
AN XY:
457794
show subpopulations
African (AFR)
AF:
0.0129
AC:
232
AN:
18008
American (AMR)
AF:
0.0578
AC:
396
AN:
6850
Ashkenazi Jewish (ASJ)
AF:
0.112
AC:
972
AN:
8698
East Asian (EAS)
AF:
0.0000955
AC:
1
AN:
10468
South Asian (SAS)
AF:
0.0305
AC:
869
AN:
28508
European-Finnish (FIN)
AF:
0.122
AC:
1136
AN:
9280
Middle Eastern (MID)
AF:
0.0545
AC:
117
AN:
2148
European-Non Finnish (NFE)
AF:
0.147
AC:
122713
AN:
837078
Other (OTH)
AF:
0.111
AC:
3706
AN:
33388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
5778
11556
17333
23111
28889
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5454
10908
16362
21816
27270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.104
AC:
15294
AN:
147210
Hom.:
1146
Cov.:
32
AF XY:
0.102
AC XY:
7301
AN XY:
71650
show subpopulations
African (AFR)
AF:
0.0261
AC:
1072
AN:
41000
American (AMR)
AF:
0.107
AC:
1582
AN:
14840
Ashkenazi Jewish (ASJ)
AF:
0.134
AC:
456
AN:
3392
East Asian (EAS)
AF:
0.000596
AC:
3
AN:
5036
South Asian (SAS)
AF:
0.0295
AC:
142
AN:
4820
European-Finnish (FIN)
AF:
0.164
AC:
1442
AN:
8768
Middle Eastern (MID)
AF:
0.0552
AC:
16
AN:
290
European-Non Finnish (NFE)
AF:
0.155
AC:
10243
AN:
66110
Other (OTH)
AF:
0.111
AC:
227
AN:
2050
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
676
1351
2027
2702
3378
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
170
340
510
680
850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0838
Hom.:
195

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 26310622, 18164066, 23478260) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Macular degeneration Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CARASIL syndrome Benign:1Other:1
Jun 01, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

not specified Benign:1
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
10
DANN
Benign
0.83
PhyloP100
-1.2
PromoterAI
0.049
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2293870; hg19: chr10-124221276; API